mitoxantrone has been researched along with Cholera Infantum in 15 studies
Mitoxantrone: An anthracenedione-derived antineoplastic agent.
mitoxantrone : A dihydroxyanthraquinone that is 1,4-dihydroxy-9,10-anthraquinone which is substituted by 6-hydroxy-1,4-diazahexyl groups at positions 5 and 8.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The combination of paclitaxel and mitoxantrone is active, easily administered, and well tolerated in the treatment of metastatic breast cancer." | 9.10 | Paclitaxel and mitoxantrone in the treatment of metastatic breast cancer: a phase II trial of the Minnie Pearl Cancer Research Network. ( Calvert, S; Greco, FA; Hainsworth, JD, 2002) |
| "The combination of paclitaxel and mitoxantrone is active, easily administered, and well tolerated in the treatment of metastatic breast cancer." | 5.10 | Paclitaxel and mitoxantrone in the treatment of metastatic breast cancer: a phase II trial of the Minnie Pearl Cancer Research Network. ( Calvert, S; Greco, FA; Hainsworth, JD, 2002) |
| "The most effective regimen for relapsed acute myeloid leukemia (AML) patients who do not achieve complete remission (CR) after a course of salvage therapy has not been established." | 2.77 | Fludarabine and cytarabine in patients with relapsed acute myeloid leukemia refractory to initial salvage therapy. ( Agha, M; Boyiadzis, M; Duggal, S; Hou, JZ; Im, A; Lin, Y; McLaughlin, B; Raptis, A; Redner, R; Smith, C, 2012) |
| " However, some trials showed that increasing the dosage of anthracyclines within induction therapy improved treatment outcome substantially." | 2.70 | Intensified double induction therapy with high dose mitoxantrone, etoposide, m-amsacrine and high dose ara-C for elderly acute myeloid leukemia patients aged 61-65 years. ( Aulitzky, W; Bodenstein, H; Clemens, M; Ehninger, G; Illmer, T; Neubauer, A; Repp, R; Schaich, M; Schäkel, U; Soucek, S; Wandt, H, 2002) |
| " The maximal acceptable dosage of mitoxantrone was 10 mg/m2 x 2 due to serious hematologic toxicity." | 2.69 | Mitoxantrone-DHAP with GM-CSF: an active but myelosuppressive salvage therapy for relapsed/refractory aggressive non-Hodgkin's lymphoma. ( Berinstein, NL; Franssen, E; Haq, R; Sawka, CA, 1999) |
| "To date, all available therapies for prostate cancer are plagued by adverse effects." | 2.41 | Complications of chemotherapy for prostate cancer. ( Beer, TM; Bubalo, JS, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (6.67) | 18.7374 |
| 1990's | 6 (40.00) | 18.2507 |
| 2000's | 6 (40.00) | 29.6817 |
| 2010's | 2 (13.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Litzow, MR | 1 |
| Wang, XV | 1 |
| Carroll, MP | 1 |
| Karp, JE | 1 |
| Ketterling, RP | 1 |
| Zhang, Y | 1 |
| Kaufmann, SH | 1 |
| Lazarus, HM | 1 |
| Luger, SM | 1 |
| Paietta, EM | 1 |
| Pratz, KW | 1 |
| Tun, HW | 1 |
| Altman, JK | 1 |
| Broun, ER | 1 |
| Rybka, WB | 1 |
| Rowe, JM | 1 |
| Tallman, MS | 1 |
| McLaughlin, B | 1 |
| Im, A | 1 |
| Raptis, A | 1 |
| Agha, M | 1 |
| Hou, JZ | 1 |
| Redner, R | 1 |
| Duggal, S | 1 |
| Lin, Y | 1 |
| Smith, C | 1 |
| Boyiadzis, M | 1 |
| Schaich, M | 1 |
| Illmer, T | 1 |
| Aulitzky, W | 1 |
| Bodenstein, H | 1 |
| Clemens, M | 1 |
| Neubauer, A | 1 |
| Repp, R | 1 |
| Schäkel, U | 1 |
| Soucek, S | 1 |
| Wandt, H | 1 |
| Ehninger, G | 1 |
| Hainsworth, JD | 1 |
| Calvert, S | 1 |
| Greco, FA | 1 |
| Osman, I | 1 |
| Akin, U | 1 |
| Ismet, A | 1 |
| Meral, B | 1 |
| Hamdi, A | 1 |
| Haluk, K | 1 |
| Thomas, X | 1 |
| Elhamri, M | 1 |
| Chelghoum, Y | 1 |
| Reman, O | 1 |
| Arnaud, P | 1 |
| Raffoux, E | 1 |
| Le, QH | 1 |
| Tavernier, E | 1 |
| Dombret, H | 1 |
| Michallet, M | 1 |
| Tan, RM | 1 |
| Quah, TC | 1 |
| Aung, L | 1 |
| Liang, S | 1 |
| Kirk, RC | 1 |
| Yeoh, AE | 1 |
| Chisesi, T | 1 |
| Bellesi, G | 1 |
| Rigacci, L | 1 |
| Alterini, R | 1 |
| Bernardi, F | 1 |
| Stefanacci, S | 1 |
| Innocenti, F | 1 |
| Fusco, II | 1 |
| Longo, G | 1 |
| Di Lollo, S | 1 |
| Ferrini, PR | 1 |
| Higashigawa, M | 1 |
| Hori, H | 1 |
| Hirayama, M | 1 |
| Kawasaki, H | 1 |
| Ido, M | 1 |
| Azuma, E | 1 |
| Sakurai, M | 1 |
| Haq, R | 1 |
| Sawka, CA | 1 |
| Franssen, E | 1 |
| Berinstein, NL | 1 |
| Feldman, EJ | 1 |
| Seiter, K | 1 |
| Traganos, F | 1 |
| Darzynkiewicz, Z | 1 |
| Goff, H | 1 |
| Pozzuoli, M | 1 |
| Baskind, P | 1 |
| Santos, S | 1 |
| Ahmed, T | 1 |
| Beer, TM | 1 |
| Bubalo, JS | 1 |
| Kreisle, WH | 1 |
| Alberts, DS | 1 |
| List, AF | 1 |
| McCloskey, T | 1 |
| Plezia, P | 1 |
| Peng, YM | 1 |
| George, M | 1 |
| Shenkenberg, TD | 1 |
| Von Hoff, DD | 1 |
2 reviews available for mitoxantrone and Cholera Infantum
| Article | Year |
|---|---|
Complications of chemotherapy for prostate cancer.
Topics: Adenocarcinoma; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Docetaxel; Ga | 2001 |
Mitoxantrone: a new anticancer drug with significant clinical activity.
Topics: Adult; Animals; Anthraquinones; Antineoplastic Agents; Breast Neoplasms; Child; Clinical Trials as T | 1986 |
12 trials available for mitoxantrone and Cholera Infantum
| Article | Year |
|---|---|
A randomized trial of three novel regimens for recurrent acute myeloid leukemia demonstrates the continuing challenge of treating this difficult disease.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cytarabine; Disease-Free Survival | 2019 |
Fludarabine and cytarabine in patients with relapsed acute myeloid leukemia refractory to initial salvage therapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemical and Drug Induced Liver Injury; | 2012 |
Intensified double induction therapy with high dose mitoxantrone, etoposide, m-amsacrine and high dose ara-C for elderly acute myeloid leukemia patients aged 61-65 years.
Topics: Acute Disease; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; ATP Binding | 2002 |
Paclitaxel and mitoxantrone in the treatment of metastatic breast cancer: a phase II trial of the Minnie Pearl Cancer Research Network.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Female; Gastrointesti | 2002 |
Mitoxantrone and cytosine arabinoside in previously untreated adult patients with acute non-lymphocytic leukemia.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Cytar | 1996 |
Intensive chemotherapy with mitoxantrone administered as a single injection in patients with high-risk acute myeloid leukemia: results of the EMA 2000 trial.
Topics: Acute Disease; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow | 2005 |
The rationale of therapy with mitoxantrone in non-Hodgkin's lymphoma. The Non-Hodgkin's Lymphoma Co-operative Study Group, (NHLCSG) Italy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Cyclophosphamide; | 1993 |
A new protocol (MiCEP) for the treatment of intermediate or high-grade non-Hodgkin's lymphoma in the elderly.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; Etopo | 1996 |
Mitoxantrone-DHAP with GM-CSF: an active but myelosuppressive salvage therapy for relapsed/refractory aggressive non-Hodgkin's lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Dexamethasone; D | 1999 |
Phase II evaluation of a high-dose mitoxantrone based induction regimen in untreated adults with acute myeloid leukemia.
Topics: Actuarial Analysis; Acute Disease; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marro | 2000 |
A phase I trial of 14-day continuous intravenous infusion mitoxantrone.
Topics: Adult; Aged; Diarrhea; Drug Evaluation; Female; Gastrointestinal Diseases; Humans; Infusions, Intrav | 1991 |
Mitoxantrone: a new anticancer drug with significant clinical activity.
Topics: Adult; Animals; Anthraquinones; Antineoplastic Agents; Breast Neoplasms; Child; Clinical Trials as T | 1986 |
2 other studies available for mitoxantrone and Cholera Infantum
| Article | Year |
|---|---|
Improved outcome in childhood acute myeloid leukemia in Singapore with the MRC AML 10 protocol.
Topics: Acute Disease; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Chemical and | 2007 |
Salvage therapy for relapsed or refractory childhood acute lymphocytic leukemia by alternative administration a lymphoid- and myeloid-directed chemotherapeutic regimen consisting of dual modulation of ara-C, hydroxyurea, and etoposide.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow Transplantation; Child; Co | 1997 |